Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 GIP and bariatric surgery.

Literature DB >> 21082290

GIP and bariatric surgery.

Abstract

Bariatric surgery is the most effective modality of achieving weight loss as well as the most effective treatment for type 2 diabetes mellitus (T2DM). Glucose-dependent insulinotropic polypeptide (GIP) is an incretin and is implicated in the pathogenesis of obesity and T2DM. Its role in weight loss and resolution of T2DM after bariatric surgery is very controversial. We have made an attempt to review the physiology of GIP and its role in weight loss and resolution of T2DM after bariatric surgery. We searched PubMed and included all relevant original articles (both human and animal) in the review. Whereas most human studies have shown a decrease in GIP post-malabsorptive bariatric surgery, the role of GIP in bariatric surgery done in animal experiments remains inconclusive.

Entities: Disease Gene Species

Mesh：

Substances：

Year: 2011 PMID： 21082290 DOI： 10.1007/s11695-010-0305-x

Source DB: PubMed Journal: Obes Surg ISSN： 0960-8923 Impact factor: 4.129

67 in total

1. The effect of duodenal-jejunal bypass on glucose-dependent insulinotropic polypeptide secretion in Wistar rats.

Authors: Tammy L Kindel; Stephanie M Yoder; David A D'Alessio; Patrick Tso
Journal: Obes Surg Date: 2010-02-23 Impact factor: 4.129

2. Glucose-dependent insulinotropic polypeptide (GIP) stimulation of pancreatic beta-cell survival is dependent upon phosphatidylinositol 3-kinase (PI3K)/protein kinase B (PKB) signaling, inactivation of the forkhead transcription factor Foxo1, and down-regulation of bax expression.

Authors: Su-Jin Kim; Kyle Winter; Cuilan Nian; Makoto Tsuneoka; Yoshiro Koda; Christopher H S McIntosh
Journal: J Biol Chem Date: 2005-04-06 Impact factor: 5.157

3. Defective glucose-dependent insulinotropic polypeptide receptor expression in diabetic fatty Zucker rats.

Authors: F C Lynn; N Pamir; E H Ng; C H McIntosh; T J Kieffer; R A Pederson
Journal: Diabetes Date: 2001-05 Impact factor: 9.461

4. Etiology of type II diabetes mellitus: role of the foregut.

Authors: W J Pories; R J Albrecht
Journal: World J Surg Date: 2001-04-18 Impact factor: 3.352

5. Effect of duodenal-jejunal exclusion in a non-obese animal model of type 2 diabetes: a new perspective for an old disease.

Authors: Francesco Rubino; Jacques Marescaux
Journal: Ann Surg Date: 2004-01 Impact factor: 12.969

6. Glucose-dependent insulinotropic polypeptide promotes beta-(INS-1) cell survival via cyclic adenosine monophosphate-mediated caspase-3 inhibition and regulation of p38 mitogen-activated protein kinase.

Authors: Jan A Ehses; Vanbric R Casilla; Tim Doty; J Andrew Pospisilik; Kyle D Winter; Hans-Ulrich Demuth; Raymond A Pederson; Christopher H S McIntosh
Journal: Endocrinology Date: 2003-06-19 Impact factor: 4.736

7. Elevated plasma glucose-dependent insulinotropic polypeptide associates with hyperinsulinemia in impaired glucose tolerance.

Authors: Michael J Theodorakis; Olga Carlson; Denis C Muller; Josephine M Egan
Journal: Diabetes Care Date: 2004-07 Impact factor: 19.112

8. Characterisation of the processing by human neutral endopeptidase 24.11 of GLP-1(7-36) amide and comparison of the substrate specificity of the enzyme for other glucagon-like peptides.

Authors: K Hupe-Sodmann; G P McGregor; R Bridenbaugh; R Göke; B Göke; H Thole; B Zimmermann; K Voigt
Journal: Regul Pept Date: 1995-08-22

9. Hormonal changes after Roux-en Y gastric bypass for morbid obesity and the control of type-II diabetes mellitus.

Authors: Ronald H Clements; Quintin H Gonzalez; Calvin I Long; Gary Wittert; Henry L Laws
Journal: Am Surg Date: 2004-01 Impact factor: 0.688

10. First-phase insulin secretion restoration and differential response to glucose load depending on the route of administration in type 2 diabetic subjects after bariatric surgery.

Authors: Serenella Salinari; Alessandro Bertuzzi; Simone Asnaghi; Caterina Guidone; Melania Manco; Geltrude Mingrone
Journal: Diabetes Care Date: 2008-11-25 Impact factor: 19.112

31 in total

Review 1. Bone Health following Bariatric Surgery: Implications for Management Strategies to Attenuate Bone Loss.

Authors: Tair Ben-Porat; Ram Elazary; Shiri Sherf-Dagan; Ariela Goldenshluger; Ronit Brodie; Yoav Mintz; Ram Weiss
Journal: Adv Nutr Date: 2018-03-01 Impact factor: 8.701

2. Comparison of different gastric bypass procedures in gastric carcinoma patients with type 2 diabetes mellitus.

Authors: Shao-Wei Xiong; Dong-Yun Zhang; Xian-Ming Liu; Zeng Liu; Fang-Ting Zhang
Journal: World J Gastroenterol Date: 2014-12-28 Impact factor: 5.742

Review 3. Gastrointestinal changes after bariatric surgery.

Authors: I Quercia; R Dutia; D P Kotler; S Belsley; B Laferrère
Journal: Diabetes Metab Date: 2013-12-17 Impact factor: 6.041

Review 4. Physiology of weight loss surgery.

Authors: Chan W Park; Alfonso Torquati
Journal: Surg Clin North Am Date: 2011-12 Impact factor: 2.741

5. Effects of Sleeve Gastrectomy and Gastric Bypass on Postprandial Lipid Profile in Obese Type 2 Diabetic Patients: a 2-Year Follow-up.

Authors: E Griffo; M Cotugno; G Nosso; G Saldalamacchia; A Mangione; L Angrisani; A A Rivellese; B Capaldo
Journal: Obes Surg Date: 2016-06 Impact factor: 4.129

6. Duodenal Exclusion but Not Sleeve Gastrectomy Preserves Insulin Secretion, Making It the More Effective Metabolic Procedure.

Authors: Claudia Laessle; Gergana Nenova; Goran Marjanovic; Gabriel Seifert; Lampros Kousoulas; Bernd Jaenigen; Stefan Fichtner-Feigl; Jodok Matthias Fink
Journal: Obes Surg Date: 2018-05 Impact factor: 4.129